Distress Related to the Feeling of Loss of Dignity in Patients With Rheumatic Diseases

• Conditions: Quality of Life; Dignity; Distress, Emotional; Rheumatic Diseases
• Interventions: Other: The Patient Dignity Inventory instrument (PDI); Other: WHOQOL-BREF (quality of life) instrument

• Registration Number: NCT05248464
• Lead Sponsor: National Institute of Medical Sciences and Nutrition, Salvador Zubiran

Brief Summary

Rheumatic diseases (RD) are an important group of different clinical entities and specific diseases that affect a significant proportion of the world population. In Mexico, the RD have a relevant representation in the adult population.

Dignity is a construct characterized by the representation of the self, of the self from others' point of view, and of the interaction of the individual with the environment and social context.

Living with a chronic illness can threaten experiences of dignity for the sick person and their families. Various studies have demonstrated the direct impact of the disease on dignity in terms of physical and psychological symptoms and loss of function. Some efforts have been made to operationalize the concept of perceived dignity in the context of chronic diseases

The perceived dignity of patients and the distress related to the feeling of loss of dignity (DRFLD) are outcomes that the patient can report and that the doctors can evaluate to be incorporated into the considerations of comprehensive care. Both outcomes are closely related, perceived dignity refers to a complex phenomenon, while distress related to the feeling of loss of dignity identifies those patients with a perceived dignity compromise of such magnitude that it generates anguish.

Detailed Description

The Patient Dignity Inventory (PDI) is an instrument originally written in English made up of 25 items integrated into 5 factors that include: symptoms, existential anguish, dependency, peace of mind and social support. Has a Likert-type response system with a 5-point scale, ranging from 1 ''not a problem'' to 5 ''very serious problem"; higher scores indicate greater dignity-related distress.

The PDI has been translated and validated into different languages, including validation in Spanish. The PDI instrument was validated in Mexico by Rodríguez-Mayoral et al., in 290 cancer patients. It had very good reliability with an alpha of 0.95 and a 4-factor structure that explained 64% of the variance (loss of meaning in life, loss of autonomy, dependency, and social support).

The primary objective of the study is the association between the presence of distress related to the feeling of loss of dignity and quality of life in patients with RD

Study Timeline

• Study First Submitted: 2022-01-30
• Status Verified: 2022-02
• Study First Submitted QC: 2022-02-10
• Study First Posted: 2022-02-21
• Study Start: 2022-03-01
• Last Update Submitted: 2022-04-04
• Last Update Posted: 2022-04-06
• Primary Completion: 2023-03-01
• Study Completion: 2023-03-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 309

Inclusion Criteria

• Patients with a rheumatic disease diagnosis according to their primary rheumatologist who agree to participate

Exclusion Criteria

• Patients with a not confirmed rheumatic disease

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Rheumatic diseases patients	The Patient Dignity Inventory instrument (PDI)	All the rheumatic diseases outpatients from the National Institute of Medical Sciences
Rheumatic diseases patients	WHOQOL-BREF (quality of life) instrument	All the rheumatic diseases outpatients from the National Institute of Medical Sciences

Primary Outcome Measures

Name	Time	Method
Determine the prevalence (percentage) of the presence of distress related to the feeling of loss of dignity in patients with RD	Baseline (At study inclusion)	Determine the prevalence (percentage) of the presence of distress related to the feeling of loss of dignity in patients with RD, using PDI (distress related to the feeling of loss of dignity) instrument

Secondary Outcome Measures

Name	Time	Method
Determine the quality of life in patients with RD, using WHOQOL-BREF (quality of life) instrument	Baseline (At study inclusion)	Determine the quality of life in patients with RD, using WHOQOL-BREF (quality of life) instrument

Trial Locations

Locations (1)

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán; 🇲🇽 Mexico City, Mexico